Breaking News Instant updates and real-time market news.

HZNP

Horizon Pharma

$27.51

0.63 (2.34%)

06:07
04/04/19
04/04
06:07
04/04/19
06:07

Piper sees potentially 'transformational opportunity' for Horizon Pharma

After hosting a call featuring a key opinion leader who treats a "significant number" of patients with moderate-to-severely active thyroid eye disease, Piper Jaffray analyst David Amsellem says he continues to view teprotumumab as a "potentially transformational opportunity" for Horizon Pharma. The commentary on the call "clearly underscores the extent to which systemic corticosteroids are inadequate for these patients," Amsellem tells investors in a research note. He believes experts views teprotumumab as "potentially paradigm-shifting" and reiterates an Overweight rating on Horizon Pharma with a $33 price target.

  • 06

    Apr

HZNP Horizon Pharma
$27.51

0.63 (2.34%)

04/03/19
CANT
04/03/19
NO CHANGE
Target $32
CANT
Overweight
Horizon Pharma price target raised to $32 from $26 at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen raised her price target for Horizon Pharma to $32 from $26 after updating her model to reflect the recent equity offering and sales for teprotumumab starting in 2020 given the positive Phase 3 results earlier this year. She says both events support her Overweight rating on Horizon Pharma.
03/27/19
PIPR
03/27/19
NO CHANGE
Target $33
PIPR
Overweight
Horizon Pharma remains a high conviction idea at Piper Jaffray
Piper Jaffray analyst David Amsellem reiterates an Overweight rating on Horizon Pharma with a $33 price target after hosting investor meetings with management. The analyst gained additional insights into the drivers of Krystexxa volume growth, as well as further insights into additional data points later this year and beyond for teprotumumab in thyroid eye disease. He sees "strong visibility" into a longer-term annual EBITDA growth "that could easily approach" 20%, driven primarily by continued growth in Krystexxa adoption and growing contribution from teprotumumab. Further multiple expansion for Horizon Pharma is a "reasonable expectation," Amsellem tells investors in a research note. The company remains one of the analyst's highest conviction ideas.
03/08/19
03/08/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Horizon Pharma (HZNP) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger citing the stock's 6% slide on March 5 due to its disclosure of the receipt of a civil investigative demand from the DOJ, noting that management responded by conveying high confidence in the company's legal compliance. 2. SeaWorld (SEAS) upgraded to Outperform from Neutral at Macquarie. 3. Buckeye Partners (BPL) upgraded to Buy from Neutral at UBS with analyst Shneur Gershuni saying after reviewing the company's annual report, the analyst sees better leverage metrics for Buckeye relative to what he previously thought. 4. WageWorks (WAGE) upgraded to Outperform from Market Perform at Wells Fargo with analyst Jamie Stockton saying he believes WageWorks will get its financials restated reasonably soon, and this restatement should not materially affect estimates. 5. BCE (BCE) upgraded to Buy from Hold at Argus with analyst John Eade citing the company's position as the largest communications entity in Canada and his expectations of consistent income for investors. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/08/19
MSCO
03/08/19
UPGRADE
Target $32
MSCO
Overweight
Morgan Stanley ups Horizon Pharma to Overweight, says pivot underappreciated
Morgan Stanley analyst David Risinger upgraded Horizon Pharma to Overweight from Equal Weight in the wake of the stock's 6% slide on March 5 due to its disclosure of the receipt of a civil investigative demand from the DOJ, noting that management responded by conveying high confidence in the company's legal compliance. Meanwhile, he believes the company's transition to rare diseases is underappreciated and the stock's valuation is compelling. The analyst, who forecasts 2023 orphan/rheumatology sales of $1.96B, compared to consensus of $1.51B, maintains a $32 price target on Horizon shares.

TODAY'S FREE FLY STORIES

CRC

California Resources

$22.75

-3.55 (-13.50%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
California Resources falls -13.4% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 08

    May

HZO

MarineMax

$16.59

-3.255 (-16.41%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
MarineMax falls -16.3% »

MarineMax is down -16.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CLS

Celestica

$7.19

-1.42 (-16.50%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Celestica falls -16.7% »

Celestica is down -16.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

AAN

Aaron's

$58.07

4.745 (8.90%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Aaron's rises 9.0% »

Aaron's is up 9.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 13

    Nov

WAB

Wabtec

$71.90

-4.67 (-6.10%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Options
Downside put buy in Wabtec as shares wobble after earnings »

Downside put buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

  • 13

    Nov

OIS

Oil States

$20.53

2.11 (11.45%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Oil States rises 12.4% »

Oil States is up 12.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

ASPN

Aspen Aerogels

$3.56

0.36 (11.25%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Aspen Aerogels rises 12.7% »

Aspen Aerogels is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 28

    May

NWL

Newell Brands

$13.84

-0.4 (-2.81%)

11:55
04/25/19
04/25
11:55
04/25/19
11:55
Options
Newell Brands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 07

    May

  • 14

    May

  • 15

    May

  • 16

    May

  • 17

    May

11:50
04/25/19
04/25
11:50
04/25/19
11:50
General news
U.S. Treasury tax receipts continue to surge »

U.S. Treasury tax…

GILD

Gilead

$63.57

0.75 (1.19%)

11:48
04/25/19
04/25
11:48
04/25/19
11:48
Recommendations
Gilead analyst commentary at Piper Jaffray »

Piper Jaffray 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 02

    May

  • 03

    May

  • 06

    May

  • 08

    May

  • 18

    May

IMMR

Immersion

$9.27

0.03 (0.32%)

11:45
04/25/19
04/25
11:45
04/25/19
11:45
Options
Immersion call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
04/25/19
04/25
11:45
04/25/19
11:45
General news
Treasury's $85 B 4- and 8-week bill auctions were mixed »

Treasury's $85 B 4-…

11:43
04/25/19
04/25
11:43
04/25/19
11:43
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

11:43
04/25/19
04/25
11:43
04/25/19
11:43
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

FB

Facebook

$193.51

10.87 (5.95%)

, TSLA

Tesla

$251.50

-7.2 (-2.78%)

11:38
04/25/19
04/25
11:38
04/25/19
11:38
On The Fly
Facebook upgrade, Tesla downgrade among today's top calls »

Check out today's top…

FB

Facebook

$193.51

10.87 (5.95%)

TSLA

Tesla

$251.50

-7.2 (-2.78%)

PTC

PTC

$90.78

-11.16 (-10.95%)

XLNX

Xilinx

$116.64

-23.15 (-16.56%)

GD

General Dynamics

$178.46

-2.21 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 01

    May

  • 14

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

PAGS

PagSeguro Digital

$26.34

-0.14 (-0.53%)

11:35
04/25/19
04/25
11:35
04/25/19
11:35
Options
PagSeguro Digital put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

ZAYO

Zayo Group

$30.67

-1.075 (-3.39%)

11:31
04/25/19
04/25
11:31
04/25/19
11:31
Recommendations
Zayo Group analyst commentary at Wells Fargo »

Zayo weakness due to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

CGI

Symbol changed to CGIP

$0.00

(0.00%)

, CGIP

Celadon Group

$0.00

(0.00%)

11:26
04/25/19
04/25
11:26
04/25/19
11:26
Hot Stocks
Celadon Group announces resolutions of DOJ, SEC investigations »

Celadon Group announced…

CGI

Symbol changed to CGIP

$0.00

(0.00%)

CGIP

Celadon Group

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBTYK

Liberty Global

$26.04

-0.35 (-1.33%)

11:25
04/25/19
04/25
11:25
04/25/19
11:25
Options
Liberty Global call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

WABC

Westamerica

$62.57

-0.87 (-1.37%)

11:21
04/25/19
04/25
11:21
04/25/19
11:21
Hot Stocks
Westamerica increases quarterly cash dividend to 41c from 40c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

11:20
04/25/19
04/25
11:20
04/25/19
11:20
General news
Energy Action: RBOB gasoline futures »

Energy Action: RBOB…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
04/25/19
04/25
11:17
04/25/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
04/25/19
04/25
11:16
04/25/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
04/25/19
04/25
11:15
04/25/19
11:15
General news
Treasury announced $75 B in 3- and 6-month bill auctions for Monday »

Treasury announced $75 B…

11:15
04/25/19
04/25
11:15
04/25/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.